These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3830207)

  • 1. Long-term treatment of epilepsy: open multicenter trial with progabide in epileptic patients.
    Musch B; Cambier J; Loiseau P; Fournier V; Beaussart M; Benoit C; Broglin D; Cenraud M; Chatel M; Deville MC
    Eur Neurol; 1987; 26(2):113-9. PubMed ID: 3830207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progabide as an add-on drug for epilepsy refractory to high dose antiepileptic drug therapy.
    Schmidt D
    Neurosci Lett; 1984 Jun; 47(3):357-60. PubMed ID: 6382068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progabide for refractory partial epilepsy: a controlled add-on trial.
    Schmidt D; Utech K
    Neurology; 1986 Feb; 36(2):217-21. PubMed ID: 3511402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.
    Martínez-Lage JM; Bossi L; Morales G; Martínez Vila E; Orofiamma B; Viteri C
    Epilepsia; 1984 Oct; 25(5):586-93. PubMed ID: 6383790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind crossover trial of progabide versus placebo in severe epilepsies.
    Loiseau P; Bossi L; Guyot M; Orofiamma B; Morselli PL
    Epilepsia; 1983 Dec; 24(6):703-15. PubMed ID: 6357772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patients.
    de Pasquet EG; Scaramelli A; de Cáceres MP; L'Héritier C; Feldman S; Santana R; Aguilar J; Musch B; Morselli PL
    Epilepsia; 1991; 32(1):133-9. PubMed ID: 1985823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progabide: a controlled trial in partial epilepsy.
    Dam M; Gram L; Philbert A; Hansen BS; Lyon BB; Christensen JM; Angelo HR
    Epilepsia; 1983 Apr; 24(2):127-34. PubMed ID: 6403342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary observations on the activity of progabide, administered as monotherapy in complex partial seizures.
    Benassi E; Besio G; Bo GP; Cocito L; Maffini M; Mainardi P; Morselli PL; Loeb C
    Int J Clin Pharmacol Res; 1988; 8(5):353-61. PubMed ID: 3068161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of progabide and its active metabolite in epileptic patients: relationships to the therapeutic outcome.
    Benassi E; Morselli PL; Besio G; Bianchetti G; Loeb C
    Int J Clin Pharmacol Res; 1988; 8(6):409-13. PubMed ID: 3253218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open label trial with vigabatrin in children with intractable epilepsy.
    Wong V
    Brain Dev; 1995; 17(4):249-52. PubMed ID: 7503385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.
    Crawford P; Chadwick D
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1251-7. PubMed ID: 3098923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin treatment in children.
    Fois A; Buoni S; Di Bartolo RM; Di Marco V; Mostardini R
    Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of progabide and its acid metabolite by reversed-phase high-performance liquid chromatography.
    Decourt JP; Mura P; Papet Y; Piriou A; Reiss D
    J Chromatogr; 1990 Apr; 527(1):214-9. PubMed ID: 2365784
    [No Abstract]   [Full Text] [Related]  

  • 19. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K; Sander JW
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.